Insider: Delaet Ingrid Chief Regulatory Officer - NEUROCRINE BIOSCIENCES INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 4,730 | 0 | 4,730 |
| Value | $666,409.70 | $0.00 | $666,409.70 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 07/10/2025 | DDS | 457 | Direct | COM | $135.00 | $61,695.00 | 4,730 |
| 02/13/2025 | DDS | 716 | Direct | COM | $116.69 | $83,549.47 | 4,084 |
| 02/13/2025 | DDS | 755 | Direct | COM | $116.72 | $88,124.66 | 4,730 |
| 02/03/2025 | DDS | 623 | Direct | COM | $149.29 | $93,007.67 | 3,442 |
| 01/31/2025 | DDS | 422 | Direct | COM | $153.05 | $64,586.72 | 2,886 |
| 12/31/2024 | DDS | 272 | Direct | COM | $138.10 | $37,563.20 | 2,507 |
| 12/17/2024 | DDS | 1,091 | Direct | COM | $135.00 | $147,285.00 | 2,507 |
| 08/13/2024 | DDS | 3,043 | Direct | COM | $150.13 | $456,847.11 | 6,607 |
| 08/13/2024 | DDS | 4,100 | Direct | COM | $150.08 | $615,333.33 | 2,507 |
| 08/06/2024 | DDS | 273 | Direct | COM | $147.70 | $40,322.10 | 6,607 |
| 07/01/2024 | DDS | 272 | Direct | COM | $138.11 | $37,565.92 | 7,507 |
| 05/31/2024 | DDS | 273 | Direct | COM | $136.55 | $37,278.15 | 7,507 |
| 05/06/2024 | DDS | 273 | Direct | COM | $140.55 | $38,370.15 | 7,507 |
| 04/01/2024 | DDS | 272 | Direct | COM | $137.30 | $37,345.60 | 7,507 |
| 03/21/2024 | DDS | 5,000 | Direct | COM | $145.06 | $725,320.00 | 7,507 |
| 03/13/2024 | DDS | 3,000 | Direct | COM | $140.14 | $420,419.40 | 7,507 |
| 03/11/2024 | DDS | 200 | Direct | COM | $140.00 | $28,000.00 | 7,507 |
| 03/08/2024 | DDS | 1,800 | Direct | COM | $140.03 | $252,052.56 | 7,507 |
| 02/29/2024 | DDS | 273 | Direct | COM | $135.51 | $36,994.23 | 7,507 |
| 02/28/2024 | DDS | 2,500 | Direct | COM | $135.64 | $339,103.50 | 7,507 |
| 02/28/2024 | DDS | 2,500 | Direct | COM | $134.62 | $336,550.00 | 7,507 |
| 02/28/2024 | DDS | 1,544 | Direct | COM | $136.00 | $209,984.00 | 7,507 |
| 02/13/2024 | DDS | 716 | Direct | COM | $133.03 | $95,252.77 | 7,507 |
| 02/01/2024 | DDS | 623 | Direct | COM | $139.77 | $87,076.71 | 6,865 |
| 01/31/2024 | DDS | 422 | Direct | COM | $141.94 | $59,898.68 | 6,309 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research